December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 18, 2024

Major Heart Failure Trial Yields Key Data

A recent multicenter trial investigated the impact of potassium nitrate supplementation on exercise capacity and quality of life in patients with heart failure with preserved ejection fraction, revealing interesting insights into blood nitric oxide metabolites.

Conexiant

December 16, 2024

Are Dietary Guidelines Built on Solid Research?

A study evaluating systematic reviews used to develop dietary guidelines for Americans revealed 'critically low' quality and significant methodological weaknesses, raising concerns about reliability and reproducibility.

Conexiant

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant

December 16, 2024

New Four-Stage System Redefines AF Care

New atrial fibrillation management guidelines embrace a novel 4-stage classification system and early rhythm control strategy, with clinical trials showing a 21% reduction in cardiovascular outcomes when rhythm control is initiated within 12 months of diagnosis.

Conexiant

December 16, 2024

AAP Unveils Screening Protocol Changes

New guidelines for congenital heart disease screening recommend a single retest and require ≥95% oxygen saturation in both pre- and post-ductal measurements, aiming to simplify detection while maintaining accuracy.

Conexiant

December 13, 2024

Breakfast Habits Linked to Cardiometabolic Risk

Study finds both low and high breakfast energy intake are linked to worse cardiometabolic outcomes in older adults, with high energy intake associated with a striking 28.1 mg/dL increase in triglycerides compared to optimal 20-30% daily caloric intake.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

December 12, 2024

Comparing Ticagrelor and Prasugrel in ACS

In a 17,642-patient cohort study validating ISAR-REACT5's findings, prasugrel showed particular benefit in STEMI patients, with a striking 38% relative risk reduction in adverse events compared to ticagrelor, while maintaining similar bleeding risks.

Conexiant